Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

PTPN11 and leukemia are reported together in 3 articles.

Gene

PTPN11

HGNC
HGNC:9644
11articles
11mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
Phenotype

Leukemia

652articles
652mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

3 records shown · first 60

Deciphering the structural and dynamic effects of SHP2-E76 mutations: mechanistic insights into oncogenic activation.

PMID 40369628 | PMCID PMC12079960 | DOI 10.1186/s13065-025-01494-2 · BMC chemistry · 2025 · 7 validated mentions
TypeEntitySource evidenceConfidenceExtractor
genePTPN11“The tyrosine phosphatase known as SHP2 is a cytoplasmic protein and encodes by proto-oncogene PTPN11.”0.98hgnc_dict_v1
phenotypeleukemia“Specifically, a germline mutation (E76D) in SHP2 is linked to neurodevelopmental disorders, such as Noonan syndrome, while somatic mutations (E76G and E76A) and altered SHP2 expression are implicated in several forms of leukemia.”0.98phenotype_alias_lexicon_v2
phenotypeNoonan syndrome“Specifically, a germline mutation (E76D) in SHP2 is linked to neurodevelopmental disorders, such as Noonan syndrome, while somatic mutations (E76G and E76A) and altered SHP2 expression are implicated in several forms of leukemia.”0.98phenotype_alias_lexicon_v2
phenotypeneurodevelopmental disorder“Mutations in SHP2 are frequently associated with human malignancies and neurodevelopmental disorders (NDDs).”0.93phenotype_alias_lexicon_v2

Exploring the interplay between microRNA expression and DNA mutation analysis in AML patients.

PMID 38831894 | PMCID PMC11145380 | DOI 10.1016/j.sjbs.2024.104027 · Saudi journal of biological sciences · 2024 · 11 validated mentions
TypeEntitySource evidenceConfidenceExtractor
genePTPN11“The molecular analysis results unveiled mutations in specific genes (FLT3, KIT, PTPN11, BCR, DNMT3A, and NRAS) targeted by nine microRNAs.”0.98hgnc_dict_v1
phenotypeleukemia“Exploring the interplay between microRNA expression and DNA mutation analysis in AML patients.”0.93phenotype_alias_lexicon_v2
geneCD99“Cell surface protein expression analysis revealed upregulation of CD45, CD99, CD34, HLA-DR, CD38, CD13, CD33, MPO, CD15 and CD117 in AML patients.”0.98hgnc_dict_v1
geneCD34“Cell surface protein expression analysis revealed upregulation of CD45, CD99, CD34, HLA-DR, CD38, CD13, CD33, MPO, CD15 and CD117 in AML patients.”0.98hgnc_dict_v1
TypeEntitySource evidenceConfidenceExtractor
genePTPN11“Germline mutations in PTPN11 are the most common cause of NS.”0.98hgnc_dict_v1
phenotypeleukemia“Comprehensive Genomic Analysis of Noonan Syndrome and Acute Myeloid Leukemia in Adults: A Review and Future Directions.”0.98phenotype_alias_lexicon_v2
geneNPM1“Somatic mutations in NPM1 occur frequently in AML.”0.98hgnc_dict_v1
geneIDH1“Here, we describe a young adult patient with a novel combined germline PTPN11 and somatic NPM1, IDH1,and BCL6 mutations who presented with fatal AML.”0.98hgnc_dict_v1